AB186 Inhibits Migration of Triple-Negative Breast Cancer Cells and Interacts with α-Tubulin

Breast cancer is one of the leading causes of cancer-related death among females worldwide. A major challenge is to develop innovative therapy in order to treat breast cancer subtypes resistant to current treatment. In the present study, we examined the effects of two Troglitazone derivatives Δ2-TGZ...

Descripción completa

Detalles Bibliográficos
Autores principales: Geoffroy, Marine, Lemesle, Marine, Kleinclauss, Alexandra, Mazerbourg, Sabine, Batista, Levy, Barberi-Heyob, Muriel, Bastogne, Thierry, Boireau, Wilfrid, Rouleau, Alain, Dupommier, Dorian, Boisbrun, Michel, Comoy, Corinne, Flament, Stéphane, Grillier-Vuissoz, Isabelle, Kuntz, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225035/
https://www.ncbi.nlm.nih.gov/pubmed/35743305
http://dx.doi.org/10.3390/ijms23126859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225035/
https://www.ncbi.nlm.nih.gov/pubmed/35743305
http://dx.doi.org/10.3390/ijms23126859

Ejemplares similares